logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Ann-Lii Cheng

national taiwan university
H指数:102
被引数:7.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

前瞻性II期研究：一线幽门螺杆菌根除疗法对早期胃外黏膜相关淋巴组织淋巴瘤的治疗效果

Blood Cancer Journal
IF11.6
2026-05-290
OAAI
Ming Yao; Xavier Cheng-Hong Tsai; Chung-Wu Lin; Shu-Lang Liao; Cheng-Ping Wang; Wei-Li Ma; Yi-Hsuan Wei; Hsiao-Wei Lee; Jyh-Ming Liou; Wei-Li Chen; I-Jong Wang; Ann-Lii Cheng; Sung-Hsin Kuo
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration

Nivolumab联合ipilimumab治疗潜在可切除的肝细胞癌：长期疗效与生物标志物探索

Journal of Hepatology
IF33
2025-09-170
PREAI
Yih-Jyh Lin; Da-Liang Ou; Yung-Yeh Su; Chia-Lang Hsu; Chin-Fu Hsiao; Bor-Sheng Ko; San-Chi Chen; Hung-Wei Wang; Jing-Houng Wang; Yao-Ming Wu; Yung-Ming Jeng; Wei-Chen Lee; Shu-Cheng Chou; Teng-Wei Chen; Chang-Fang Chiu; null Shiuan Lin; Ching-Hung Hsieh; Chi-Chun Lee; Yen-Shen Shen; Ann-Lii Cheng; Li-Tzong Chen; Chiun Hsu
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

《柳叶刀》关于应对全球肝细胞癌负担的委员会报告：从预防到治疗的综合策略

lancet
IF0
2025-07-280
PRE
Stephen Lam Chan; Hui-Chuan Sun; Yang Xu; Hongmei Zeng; Hashem B El-Serag; Jeong Min Lee; Myron E Schwartz; Richard S Finn; Jinsil Seong; Xin Wei Wang; Valérie Paradis; Ghassan K Abou-Alfa; Lorenza Rimassa; Jia-Horng Kao; Bo-Heng Zhang; Josep M Llovet; Jordi Bruix; Terry Cheuk-Fung Yip; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Landon L Chan; Man-Qi Liu; Qiang Gao; Feng Shen; Robin Kate Kelley; Ann-Lii Cheng; Masayuki Kurosaki; Hidenori Toyoda; Wei-Xia Chen; Takamichi Murakami; Ping Liang; Jessica Zucman-Rossi; Yasunori Minami; Shiro Miyayama; Kui Wang; Kwan Man; Kiyoshi Hasegawa; Qiu Li; Kaoru Tsuchiya; Li Xu; Valerie Chew; Pierce Chow; Yujin Hoshida; Amaia Lujambio; Irene Oi-Lin Ng; Michiie Sakamoto; Young Nyun Park; Thomas Yau; Masatoshi Kudo; Jia Fan; Jian Zhou
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma

LEAP-002研究：lenvatinib联合pembrolizumab对比lenvatinib单药作为晚期肝细胞癌一线治疗的健康相关生活质量分析

ESMO Open
IF8.3
2025-06-010
OA
R.S. Finn; M. Kudo; P. Merle; T. Meyer; S. Qin; M. Ikeda; R. Xu; J. Edeline; B.-Y. Ryoo; Z. Ren; A.-L. Cheng; P.R. Galle; S. Kaneko; H. Kumada; S. Kamble; J.M. Norquist; K. Mody; A. Wang; L. Dubrovsky; J.M. Llovet
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-249.

[1] Sung H, Ferlay J, Siegel RL, 等. 全球癌症统计数据2020：185个国家36种癌症的全球发病率与死亡率GLOBOCAN估算. CA Cancer J Clin 2021;71:209-249.

JHEP REPORTS
IF7.5
2025-02-010
PRE
Finn, Richard S.; Gu, Kangsheng; Chen, Xi; Merle, Philippe; Lee, Kyung-Hun; Bouattour, Mohamed; Cao, Peiguo; Wang, Wei; Cheng, Ann-Lii; Zhu, Liangjun; Lim, Ho Yeong; Kudo, Masatoshi; Pan, Yueyin; Chang, Ting-Tsung; Edeline, Julien; Li, Wei; Yang, Ping; Li, Chen; Li, Jianfeng; Siegel, Abby B.; Qin, Shukui
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
HEPATOLOGY INTERNATIONAL
IF6.1
2024-11-212
OA
Lau, George; Obi, Shuntaro; Zhou, Jian; Tateishi, Ryosuke; Qin, Shukui; Zhao, Haitao; Otsuka, Motoyuki; Ogasawara, Sadahisa; George, Jacob; Chow, Pierce K. H.; Cai, Jianqiang; Shiina, Shuichiro; Kato, Naoya; Yokosuka, Osamu; Oura, Kyoko; Yau, Thomas; Chan, Stephen L.; Kuang, Ming; Ueno, Yoshiyuki; Chen, Minshan; Cheng, Ann-Lii; Cheng, Gregory; Chuang, Wan-Long; Baatarkhuu, Oidov; Bi, Feng; Dan, Yock Young; Gani, Rino A.; Tanaka, Atsushi; Jafri, Wasim; Jia, Ji-Dong; Kao, Jia-Horng; Hasegawa, Kiyoshi; Lau, Patrick; Lee, Jeong Min; Liang, Jun; Liu, Zhenwen; Lu, Yinying; Pan, Hongming; Payawal, Diana A.; Rahman, Salimur; Seong, Jinsil; Shen, Feng; Shiha, Gamal; Song, Tianqiang; Sun, Hui-Chuan; Masaki, Tsutomu; Sirachainan, Ekaphop; Wei, Lai; Yang, Jin Mo; Sallano, Jose D.; Zhang, Yanqiao; Tanwandee, Tawesak; Dokmeci, Akadir; Zheng, Shu-sen; Fan, Jia; Fan, Sheung-Tat; Sarin, Shiv Kumar; Omata, Masao
Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis to assess the impact of treatment with camrelizumab plus rivoceranib (cam plus rivo) on quality of life vs sorafenib (sora) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study CARES-310

质量调整无症状或无毒性时间（Q-TWiST）分析，以评估卡瑞利珠单抗联合瑞戈非尼（cam plus rivo）治疗与索拉非尼（sora）相比，对不可切除肝癌（uHCC）患者（pts）生活质量的影响：CARES-310研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Moon, A.; Raphael, N.; Chan, S. L.; Kaseb, A. O.; Jang, S. H.; Meng, X.; Cheng, A-L.; Qin, S.; Vogel, A.

研究方向

暂未获取到该数据
C
Chiun Hsu
H 指数:56论文数:410被引数:1.8万
C
Chih‐Hung Hsu
H 指数:52论文数:520被引数:1.6万
Y
Yen‐Shen Lu
H 指数:48论文数:436被引数:1.2万
K
Kun‐Huei Yeh
H 指数:50论文数:396被引数:1.5万
M
Masatoshi Kudo
H 指数:143论文数:2,840被引数:12.4万
Y
Yu‐Yun Shao
H 指数:35论文数:245被引数:3,442
S
Sung‐Hsin Kuo
H 指数:43论文数:382被引数:6,073
K
Kuen‐Feng Chen
H 指数:45论文数:171被引数:5,849
P
Pei‐Jer Chen
H 指数:111论文数:1,095被引数:5.7万
Y
Ying‐Chun Shen
H 指数:31论文数:137被引数:4,107